Acquisitions - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 3 Months Ended | |||
|---|---|---|---|---|---|
May 07, 2026 |
Feb. 28, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Business Combination [Line Items] | |||||
| Acquisitions, net of cash acquired | $ 22 | $ 4,749 | |||
| Goodwill | 19,188 | $ 19,291 | |||
| MedSurg and Neurotechnology: | |||||
| Business Combination [Line Items] | |||||
| Goodwill | 11,945 | $ 12,556 | |||
| Various | |||||
| Business Combination [Line Items] | |||||
| Fair value of contingent consideration | 90 | ||||
| Goodwill | $ 3,117 | ||||
| Inari | |||||
| Business Combination [Line Items] | |||||
| Aggregate purchase price of acquisitions | $ 4,810 | ||||
| Business combination, price per share (usd per share) | $ 80 | ||||
| Business acquisition, share based compensation expense | $ 139 | ||||
| Amplitude Vascular Systems, Inc. | Subsequent Event | |||||
| Business Combination [Line Items] | |||||
| Aggregate purchase price of acquisitions | $ 435 | ||||
| Maximum amount of future milestone payments | $ 400 | ||||
| X | ||||||||||
- Definition Business Acquisition, Share Based Compensation Expense No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Maximum amount of estimate for undiscounted range of outcomes in contingent consideration arrangement in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|